Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02780414 · ClinicalTrials.gov registry record
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
A clinical trial, sponsored by Progenity.
- Completed
- Registry status
- 1,730
- Enrollment target
NCT02780414 is a clinical trial that has completed, run by Progenity. The registered enrollment target is 1,730 participants.
The verdict
NCT02780414 has completed, sponsored by Progenity.
- COMPLETED
- Registry status
- 1,730 participants
- Enrollment target
Study Summary
Preeclampsia (Pre-E) is a hypertensive disease of pregnancy with multi-system involvement that usually occurs in the second half of pregnancy. Pre-E occurs in 5% to 7% of U.S. pregnancies, and is the third-leading cause of U.S. maternal death. Improvements to the current diagnostic paradigm have been evaluated. However, no stand-alone diagnostic method has emerged that more accurately identifies women at risk for preeclampsia, warranting improvements in diagnosing Pre-E. This sample collection study will obtain serum and urine samples from pregnant women who present with clinical signs, symptoms, or conditions contributing to the suspicion of Pre-E. Samples will be used to evaluate and validate the performance of an assay intended to aid in assessing the risk of Pre-E.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,730 participants |
| Start Date | 2016-01 |
| Est. Completion | 2020-10-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02780414
The ClinicalTrials.gov registry entry for NCT02780414 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,730 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Progenity, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02780414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02780414 about?
NCT02780414 is a clinical study titled "Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers". Preeclampsia (Pre-E) is a hypertensive disease of pregnancy with multi-system involvement that usually occurs in the second half of pregnancy. Pre-E occurs in 5% to 7% of U.S. pregnancies, and is the third-leading cause of U.S. maternal death. Improvements to the current diagnostic paradigm have bee...
What is the current status of trial NCT02780414?
This trial is currently completed. The enrollment target is 1,730 participants. The study started on 2016-01. Estimated completion is 2020-10-23.
Who is sponsoring clinical trial NCT02780414?
This trial is sponsored by Progenity, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.